WHAT IS AN AIDS VACCINE?
An AIDS vaccine is an experimental strategy that aims to teach the body's immune system how to fight HIV to reduce the risk of infection or to reduce viral load in those who get the vaccine and go on to become infected. There are no AIDS vaccines available today. None of the vaccines being tested can cause HIV.WHAT'S NEW
HVAD 2013 Advocacy Toolkit:
Turning complex science into clear
messages
AVAC is pleased to share the following new
resources for HVAD 2013
- HVAD 2013: The Countdown Continues—This brochure includes snapshots of AIDS vaccine research, trials, concepts, volunteers, sites and funding, along with a timeline of key milestones over the past 25 years. (Graphics from the brochure and a PowerPoint version are also available.)
- AIDS Vaccine Science for Busy Advocates—One-pagers reviewing highlights, next steps and key terms for four pivotal topics:
- Current AIDS Vaccine R&D Pipeline
- RV144: Building on a breakthrough
- Antibody Research: Progress on a powerful immune response
- Passive Immunization: An important piece of the puzzle
- AIDS Vaccines: The basics—An introductory PowerPoint slide set with basic concepts, an overview of research status and recent developments
- AIDS Vaccine Key Messages—Bullet points on today’s pressing issues
- AIDS Vaccine Science: What's all the buzz about?—A training exercise to bring the content to life
- For a list
of HVAD events going on around the world, visit
here
- Read NIAID's
statement and updated
Q&A
- Read the AVAC statement
- Listen to a webinar featuring the trial investigators from HVTN 505
- Also available are an Advocates' Guide to Statistical Terms, a factsheet on data safety monitoring boards and a primer on what futility means in a clinical trial
Background Information
- AIDS Vaccines Then and
Now – Graphical comparisons of
numbers of AIDS vaccine trial sites,
participants and investment over the years,
May 2012
- "Inching Toward a
Vaccine," appearing in GMHC's Achieve, gives
a broad overview of vaccine field, Fall
2012
Vaccine Pipeline and Trial Candidates
- Preventative HIV vaccine trials, April 2013
- AIDS vaccine research
timeline – Graphic of current trials
grouped by vaccine concept, with timing of
results, April 2013
- Resource tracking slide
deck – Key data on spending AIDS
vaccine trends by funding source, area of
research and other metrics, May
2012
- Update of vaccine pipeline candidates, April 2013
- HIV
Vaccines: Building on success – P5
follow-up studies of RV144, March
2013
Additional Materials
- IAVI Interactive Impact Modeling Tool - Explore the interaction of future potential AIDS vaccines with existing HIV-prevention tools
- AIDS Vaccine Buzz
Groups – A participatory training
exercise using the “AIDS Vaccines for Busy
Advocates” fact sheets to bring the content
to life, May 2012
- Read "The 'Best Hope' for
AIDS Vaccine Advocacy," written by
AVAC Executive Director, Mitchell Warren,
May 2012
Introductory Information
- About Vaccines
- Introduction to AIDS Vaccines
- “AIDS Vaccine Science for Busy
Advocates” (see links above)
In-depth Resources
- Tracking the Thai Result - RV144 Page
- Understanding the results of RV144, the Thai prime-boost AIDS vaccine trial
- The Thai Way Forward
More...
Ongoing Research
More...